THP 15 Partner Services for Gonorrhea in Utah 2009-2015

Thursday, September 22, 2016
Galleria Exhibit Hall
Daniel R. Newman, MA1, Erin Fratto, MS, CHES2, Jerry Carlile, MSPH2 and Thomas Peterman, MD, MSc3, 1Epidemiology and Statistics, Centers for Disease Control and Prevention, Atlanta, GA, 2Utah Department of Health, 3Epidemiology and Statistics Branch, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA

Background: Only a few project areas provide partner services for STD other than HIV and syphilis. Utah provides partner services for gonorrhea and chlamydia.

Methods: We analyzed the Utah State Health Department surveillance records for reported gonorrhea cases from 2009-2015. Index cases were linked with their interviewed partners’ data to determine whether interviews were productive.

Results: From 2009-2015, 5,293 individual cases were diagnosed with gonorrhea in Utah. 67% were male and 33% were female. 47% of males indicated being MSM.  Median age was 29 years; 3,392 (64%) were White, 958 (18%) Hispanic, 417 (8%) Black, 526 (10%) Other/Unknown. 3,890 (73%) cases were interviewed and 2,754 identified 4,868 partners for follow-up. 79% of the initiated contacts were male and 21% were female. Median age was 30 years. The dispositions were: 409 (9%) infected, brought to treatment; 1,645 (34%) preventive treatment; 376 (8%) previously treated for infection; 1,206 (25%) insufficient information to begin investigation or unable to locate; 368 (8%) out of jurisdiction; 248 (5%) not infected; 166 (3%) located, refused exam and/or treatment; 118 (2%) refused preventative treatment; 307 (6%) were infected not treated, missing or other disposition codes. Heterosexuals named 2,229 contacts (mean=1.38, range 1-12) while MSM named 2,482 contacts (mean=1.92, range 1-28). 48% of the hetero-contacts were either treated or verified as being treated whereas 56% of MSM-contacts were treated or had verified treatment (p<.0001). Heterosexuals were more likely to be brought to treat (218, 10%) than MSM (185, 8%), (p<.003). MSM were more likely to be preventively treated (979, 41%) than heterosexuals (622, 29%), (p<.0001). Being previously treated was not significantly different between the groups: hetero (185, 9%) vs MSM (185, 8%), (p<.24).

Conclusions: Partner services provided or verified treatment for over 50% of the named contacts in Utah. Partner services were equally productive for heterosexuals and MSM.